Seguir
Mamta Kapoor Bhushan, Ph.D.
Mamta Kapoor Bhushan, Ph.D.
Dirección de correo verificada de fda.hhs.gov
Título
Citado por
Citado por
Año
The evolving landscape of drug products containing nanomaterials in the United States
SR D'Mello, CN Cruz, ML Chen, M Kapoor, SL Lee, KM Tyner
Nature nanotechnology 12 (6), 523-529, 2017
3292017
A review of intranasal formulations for the treatment of seizure emergencies
M Kapoor, JC Cloyd, RA Siegel
Journal of Controlled Release 237, 147-159, 2016
1522016
Covalent attachment of proteins to functionalized polypyrrole-coated metallic surfaces for improved biocompatibility
W Khan, M Kapoor, N Kumar
Acta biomaterialia 3 (4), 541-549, 2007
1292007
Compositions for nucleic acid delivery
M Manoharan, KG Rajeev, M Jayaraman, D Butler, M Kapoor, ...
US Patent 9,687,550, 2017
1182017
Liposomal drug product development and quality: current US experience and perspective
M Kapoor, SL Lee, KM Tyner
The AAPS journal 19, 632-641, 2017
922017
Physicochemical characterization techniques for lipid based delivery systems for siRNA
M Kapoor, DJ Burgess, SD Patil
International journal of pharmaceutics 427 (1), 35-57, 2012
812012
Efficient and safe delivery of siRNA using anionic lipids: formulation optimization studies
M Kapoor, DJ Burgess
International journal of pharmaceutics 432 (1-2), 80-90, 2012
712012
Cellular Uptake Mechanisms of Novel Anionic siRNA Lipoplexes
M Kapoor, DJ Burgess
Pharmaceutical research, 1-15, 2012
322012
Physicochemical characterization of anionic lipid-based ternary siRNA complexes
M Kapoor, DJ Burgess
Biochimica et Biophysica Acta (BBA)-Biomembranes 1818 (7), 1603-1612, 2012
322012
Rapid Delivery of Diazepam from Supersaturated Solutions Prepared Using Prodrug/Enzyme Mixtures: Toward Intranasal Treatment of Seizure Emergencies
M Kapoor, T Winter, L Lis, GI Georg, RA Siegel
The AAPS Journal, 2014
202014
Prodrug/Enzyme Based Acceleration of Absorption of Hydrophobic Drugs: An in Vitro Study
M Kapoor, RA Siegel
Molecular pharmaceutics 10 (9), 3519-3524, 2013
192013
Water-soluble benzodiazepine prodrug/enzyme combinations for intranasal rescue therapies
RA Siegel, M Kapoor, N Cheryala, GI Georg, JC Cloyd
Epilepsy & Behavior 49, 347-350, 2015
142015
Chirally pure prodrugs and their converting enzymes lead to high supersaturation and rapid transcellular permeation of benzodiazepines
M Kapoor, N Cheryala, D Rautiola, GI Georg, JC Cloyd, RA Siegel
Journal of Pharmaceutical Sciences 105 (8), 2365-2371, 2016
72016
Targeted delivery of nucleic acid therapeutics via nonviral vectors
M Kapoor, DJ Burgess
Targeted Drug Delivery: Concepts and Design, 271-312, 2015
72015
Compositions for nucleic acid delivery
M Manoharan, KG Rajeev, M Jayaraman, D Butler, M Kapoor, ...
22011
Regulatory Considerations for Cancer Drug Products Containing Nanomaterials
M Kapoor, K Hughes, KM Tyner
Nanotheranostics for Cancer Applications, 277-299, 2019
12019
Bernstein polynomial: a comprehensive review
VJM Kapoor, V Joshi
Int J Res Anal Rev (IJRAR) 5 (4), 214-219, 2018
12018
Quantum dot labeling for assessment of intracellular trafficking of therapeutically active molecules
DJ Burgess, M Kapoor
Organelle‐Specific Pharmaceutical Nanotechnology, 535-567, 2010
12010
Therapeutic compounds and formulations for intranasal delivery
RA Siegel, M Kapoor, N Cheryala, GI Georg, JC Cloyd
US Patent 10,682,310, 2020
2020
Drug delivery method
RA Siegel, J Cloyd, T Winter, M Kapoor
US Patent App. 16/161,850, 2019
2019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20